NCEL and ELDN Related Headlines

Apr 30, 2026 08:15AM NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026
Apr 20, 2026 07:38AM NewcelX updates presentation to highlight diabetes program collaboration
Mar 9, 2026 07:01AM NewcelX partners with Eledon to develop diabetes treatment
Mar 9, 2026 07:00AM NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes

NCEL and ELDN Related Press Releases

Apr 30, 2026 08:15AM NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026
Mar 9, 2026 07:00AM NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)